Page 2

Cabaletta Bio captures $50m
Autoimmune disease therapy spinout Cabaletta Bio's series B round brought its total to at least $88m allowed the university to pare back its shareholding.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Qwick recruits UAVC for $1.3m round
UAVC has returned to back UA-founded hospitality staffing platform Qwick after investing an undisclosed sum in November 2018.
Boston Scientific picks up Millipede for $325m
Boston Scientific has exercised its option to wholly acquire Millipede, based on research at Michigan, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.
Iota jots down $15m series A
UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.
Boosted hitches $60m series B ride
Stanford-StartX Fund has returned to pump funding into electric skateboard manufacturer Boosted, helping to take the company’s total funding to $70m.
Celect celebrates $15m series C
MIT retail analytics spinout Celect has now raised a total of $25m, having received $15m in an NGP Partners-led round.
IURTC funds pour $400,000 into Zio
Co-founded by an Indiana University graduate, customer behaviour analytics software developer Zio has secured funding from two of the university’s venture funds.
Elementary Robotics commands $3.6m
Osage University Partners was among the investors to supply seed funding for robotic technology developer Elementary Robotics.
Stanford's Annexon annexes $75m
Immunotherapy spinout Annexon Biosciences collected funding from Novartis Venture Fund in a series C round that brought its total funding to $154m.

test reg